The University of Alabama is a public research university in Tuscaloosa, Alabama. Established in 1820 and opened to students in 1831, the University of Alabama is the oldest and largest of the public universities in Alabama as well as the flagship of the University of Alabama System.

During the past decade, University of Alabama conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 2 clinical trials were completed, i.e. on average, 10.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 1 clinical trials were completed. i.e. 8.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Alabama" #1 sponsor was "University of Alabama, Tuscaloosa" with 13 trials, followed by "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored, "Genmab" with 1 trials sponsored, "Gladwin, Mark, MD" with 1 trials sponsored and "HealthCore-NERI" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Alabama" #1 collaborator was "University of Alabama at Birmingham" with 4 trials as a collaborator, "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 2 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "Brown University" with 1 trials as a collaborator and "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University of Alabama" are "Autism Spectrum Disorder" (3 trials), "Aging Well" (1 trials), "Alzheimer Disease" (1 trials), "Alzheimer Disease, Early Onset" (1 trials) and "Arteriovenous Fistula Stenosis" (1 trials). Many other conditions were trialed in "University of Alabama" in a lesser frequency.

Most popular intervention types in "University of Alabama" are "Behavioral" (14 trials), "Drug" (3 trials), "Other" (3 trials), "Biological" (2 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "100% watermelon juice" (1 trials), "Abbreviated cognitive behavioral therapy" (1 trials), "Avelumab" (1 trials), "Brain Health Book Club" (1 trials) and "Control" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Alabama" are 23 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "University of Alabama". 1 are not yet recruiting, 8 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in University of Alabama, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in University of Alabama, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 12 trials that are defined as “Not Applicable".